Email alerts
Advanced Search
  • Dec 2, 2010
    European Economic Analysis Shows Cost Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients
    New Findings from Sub-Analysis of REVERSE Trial Published in the European Heart Journal

    MINNEAPOLIS, Dec 02, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced findings from an economic sub-study of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left...

  • Nov 29, 2010
    Medtronic Presents One-Year Data on Endurant(R) Stent Graft
    Definitive Results from U.S. IDE Study Demonstrate Durable Safety and Effectiveness of Implantable Medical Device for Minimally Invasive Treatment of Abdominal Aortic Aneurysms

    MINNEAPOLIS & NEW YORK, Nov 19, 2010 (BUSINESS WIRE) -- An implantable medical device used in the minimally invasive treatment of abdominal aortic aneurysms, the Endurant(R) Stent Graft System...

  • Nov 29, 2010
    Medtronic Reports Second Quarter Earnings
    International Revenue of $1.6 Billion Grew 6% on a Constant Currency Basis; 4% As Reported

    MINNEAPOLIS, Nov 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2011, which ended October 29, 2010. The company...

  • Nov 22, 2010
    Medtronic Signs Agreement to Acquire Ardian

    MINNEAPOLIS & MOUNTAIN VIEW, Calif., Nov 22, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and privately-held Ardian, Inc. announced today that they have entered into a merger agreement...

  • Nov 19, 2010
    Medtronic's Reveal(R) Insertable Cardiac Monitor Led to Effective Diagnosis and Specific Treatment for Patients with Unexplained Fainting
    PICTURE Registry Results Published Online Today in EP-Europace

    MINNEAPOLIS, Nov 19, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the publication of data showing that use of its Reveal(R) family of Insertable Cardiac Monitors led to...

  • Nov 19, 2010
    Medtronic Presents 30-Day Data on Valiant(R) Thoracic Stent Graft
    Initial Results from U.S. IDE Study Demonstrate Early Safety and Effectiveness of Implantable Medical Device for Minimally Invasive Treatment of Thoracic Aortic Aneurysms

    MINNEAPOLIS & NEW YORK, Nov 19, 2010 (BUSINESS WIRE) -- An implantable medical device used in the minimally invasive treatment of thoracic aortic aneurysms,the Valiant(R) Thoracic Stent Graft...

  • Nov 18, 2010
    Medtronic Announces Global Launch of New Heart Valve Repair Ring
    Tricuspid Annuloplasty Ring is Designed to Adapt to the Heart's Natural Tricuspid Valve Acquired Through ATS Medical, New Ring Enhances Medtronic's Surgical Heart Valve Repair Portfolio

    MINNEAPOLIS, Nov 18, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch and first clinical use of the Tri-Ad(TM) Semi-Flexible Tricuspid Annuloplasty Ring for...

  • Nov 17, 2010
    Medtronic Unveils EVARpro(R) Suite of Services to Streamline Clinical Use of Aortic Stent Grafts
    New Offering Improves Pre-Case Planning, Procedural Efficiency and Patient Follow-Up

    MINNEAPOLIS, Nov 17, 2010 (BUSINESS WIRE) -- Improving the efficiency of endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), today introduced EVARpro(R), a suite of value-added...

  • Nov 16, 2010
    Medtronic Completes Acquisition of Osteotech
    Acquisition Expands Product Offering and Pipeline for Biologics Business

    MEMPHIS, Tenn., Nov 16, 2010 (BUSINESS WIRE) -- Moving to expand its Biologics product offerings, Medtronic, Inc. (NYSE: MDT), announced today it has completed the acquisition of Osteotech,...

  • Nov 15, 2010
    Medtronic Launches European Web Portal to Stimulate Medical Technology Innovation
    Medtronic Eureka seeks partnership with innovating physicians to improve healthcare

    TOLOCHENAZ, Switzerland, Nov 15, 2010 (BUSINESS WIRE) -- Medtronic today launched Medtronic Eureka, a European web-based portal for medical technology innovation designed to help physicians and...

Show 5102550100 per page